Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

NCT02342145 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

205

Enrollment

OTHER

Sponsor class

Conditions

Beta-Thalassemia Major
Graft-versus-host Disease (GVHD)

Interventions

DRUG: Basiliximab,
DRUG: Tacrolimus
DRUG: Methotrexate
DRUG: Mycophenolate mofetil

Sponsor

Zhongming Zhang

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]